Protein Powder vs Grey Market Peptides For Muscle Growth and Recovery-What is the Evidence?

本站添加: 2026-05-23

[00:00:00]Hi everyone, Dr. Michael Richmond, double board certified cardiothoracic surgeon.

[00:00:05]So in today's video, we're going to answer the question, is protein powder or a gray market peptides better at muscle growth and recovery from workouts and what is the evidence-based data show in human beings? Protein powder has substantially stronger human evidence supporting its role in muscle growth and recovery compared to gray market peptides, which really lack meaningful human clinical trial data for these indications and pretty much for all other indications.

[00:00:34]And due to the voluminous amount of human data regarding protein powder, I'm just going to mention a few of the key studies because they are important.

[00:00:42]Because there have been multiple large meta-analysis and position statements which support protein supplementation for muscle growth and recovery.

[00:00:51]So first, a meta-analysis of 49 randomized controlled trials which included about 2,000 participants found that protein supplementation during resistance training significantly increased lean muscle mass, one repetition maximum strength, and muscle fiber cross-sectional area. And the benefit plateaued at a total protein intake of 1.6 g per kilogram per day, beyond which no additional gains in lean mass were observed. And this was published in the British Journal of Sports Medicine in 2018.

[00:01:25]Next, a separate meta-analysis of 65 randomized trials, approximately 3,000 participants, confirmed protein supplementation improved lean body mass in both younger adults and older adults independent of intake timing. And this was published in the Journal of Nutrition in 2020.

[00:01:46]Protein [snorts] ingestion after exercise enhances myofibrillar protein synthesis rates, and approximately half of longer-term training studies show enhanced muscle mass and strength gains with supplementation. And this was published in a journal called Sports Medicine in 2022.

[00:02:08]So now let's look at gray market peptides where there's minimal to no human evidence. So first, let's talk about BPC-157, which you well know. So all positive data on tendon, ligament, and muscle repairs comes from rodent models. There is a single human case series that reported pain improvement after injecting it into the joint in the knee joint, but it had significant methodological flaws and no controls.

[00:02:36]The efficacy for muscle growth or recovery has never been confirmed in humans. Next, CJC-1295 plus ipamorelin showed improved muscle tension in murine models, mice, of glucocorticoid-induced muscle loss, but findings are limited only to animal studies. In general, growth hormone secretagogues, in general, can raise growth hormone and IGF-1 levels, which we all know in humans, but studies in elderly subjects showed only modest increases in lean mass with no consistent improvement in physical function or strength. Next, TB-500. It promoted the ingrowth of blood vessels and tissue repair in preclinical models, test tubes and animals, but no human orthopedic or muscle growth data exists.

[00:03:26]Now I know what you're going to say, and I'm sure I'm going to get a bunch of statements from you saying that big pharma doesn't want to do human studies because they can't make any money. Well, it's a bunch of BS, and my answer to you is stop with the nonsense and the conspiracy theories. Because if it doesn't work in rats, would you spend money to see if it works in humans? And the answer is no, you wouldn't. So now regarding safety, cuz this is new data and I've talked about this a lot. A recent JAMA, which is the premier journal, reported this year, 2026, highlighted that there have been no meaningful trials of gray market peptides in humans and that buyers cannot be certain, regardless of what you tell me or what your friend tells you or what your trusted source tells you, of product sterility or label accuracy and emerging data suggest potential risks including cardiovascular strain, which leads to heart failure, insulin resistance, abnormal lipids, in other words, high cholesterol, and psychiatric instability, particularly with supraphysiologic dosing and stacking protocols. Okay? So, what's the bottom line?

[00:04:38]For muscle growth and workout recovery, protein supplementation, particularly whey, um, at 1.4 to 2 g per kilogram per day is supported by robust human randomized controlled trial data across thousands and thousands of participants.

[00:04:56]Gray market peptides remain investigational compounds with animal data, but no validated human evidence for muscle increase in size, that means hypertrophy, or exercise recovery.

[00:05:09]Unknown dosing parameters, unregulated manufacturing, and potential for serious harm exist. So, with that, hope you learned something today. Thank you so much for listening and have a great day.